News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Human Genome Sciences, Inc. (HGSI) Says Lupus Drug Shows Positive Results


6/11/2009 8:12:39 AM

Bookmark and Share

Reuters -- Human Genome Sciences Inc said its lupus drug continued to show positive results in a mid-stage trial conducted over a period of four years, with no increase in serious adverse events, sending its shares up as much as 29 percent in trading before the bell.


Read at Reuters
Read at Wall Street Journal
Read at Market Watch
Read at RTT News
Read at Forbes


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES